Sunesis Pharmaceuticals CEO Daniel Swisher receives $819K in 2006
Sunesis Pharmaceuticals reports 2006 executive compensation
By ExecPay News
Published: April 27, 2007
Sunesis Pharmaceuticals reported fiscal year 2006 executive compensation information on April 27, 2007.
In 2006, five executives at Sunesis Pharmaceuticals received on average a compensation package of $536K.
Daniel N. Swisher, Jr, Chief Executive Officer, received $819K in total. 43% of Swisher's compensation, or $353K, was in option awards. Swisher also received $115K in bonus, $350K in salary, as well as $1.1K in other compensation.
Eric H. Bjerkholt, Chief Financial Officer, received a compensation package of $528K. 51% of the compensation package, or $268K, was in salary.
Daniel C. Adelman, Senior Vice President of Drug Discovery, earned $521K in 2006.
Daryl B. Winter, Senior Vice President of Intellectual Property, received $421K in 2006.
James W. Young, Chairman, earned $390K in 2006.
Related executives
Daniel Swisher
Sunesis Pharmaceuticals
Chief Executive Officer
Eric Bjerkholt
Sunesis Pharmaceuticals
Chief Financial Officer
Daniel Adelman
Sunesis Pharmaceuticals
Senior Vice President of Drug Discovery
Daryl Winter
Sunesis Pharmaceuticals
Senior Vice President of Intellectual Property
James Young
Sunesis Pharmaceuticals